The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy ; volume:21 ; number:1 ; day:17 ; month:10 ; year:2022 ; pages:1-17 ; date:12.2022
Molecular cancer ; 21, Heft 1 (17.10.2022), 1-17, 12.2022
- Creator
-
Croft, Wayne
Evans, Richard P. T.
Pearce, Hayden
Elshafie, Mona
Griffiths, Ewen A.
Moss, Paul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-022-01666-x
- URN
-
urn:nbn:de:101:1-2023010221013943254050
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Croft, Wayne
- Evans, Richard P. T.
- Pearce, Hayden
- Elshafie, Mona
- Griffiths, Ewen A.
- Moss, Paul
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction
High Infiltration of CD68 +/CD163 − Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma
Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction
High Infiltration of CD68 +/CD163 − Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma
Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction
High Infiltration of CD68 +/CD163 − Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma
Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer